The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancerNan Zhang, Jianan Huang, Yuanyuan Zeng et al.|International Journal of Oncology|2016Cited by 385
PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancerXiaohui Zhang, Jian-An Huang, Yuanyuan Zeng et al.|International Journal of Clinical Oncology|2017Cited by 315
The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cellsBing He, Qiang Zhang, Xuan Zhang et al.|Biomaterials|2013Cited by 223
Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancerYulong Fu, Jian‐An Huang, Yang Zhang et al.|Journal of Hematology & Oncology|2020Cited by 167
Transferrin receptor specific nanocarriers conjugated with functional 7peptide for oral drug deliveryWenwen Du, Qiang Zhang, Nan Zheng et al.|Biomaterials|2012Cited by 145